Pertuzumab-trastuzumab is a combination of two medicines used to treat a specific type of breast cancer called HER2-positive breast cancer. HER2-positive breast cancer means that the cancer cells have too much of a protein called HER2, which helps them grow and spread faster.
1. **Pertuzumab**: Pertuzumab is like a superhero medicine that fights against HER2-positive breast cancer. It works by blocking a protein called HER2 on the surface of cancer cells. This protein acts like a fuel for the cancer cells, helping them grow and spread. By blocking HER2, Pertuzumab slows down or even stops the growth of cancer cells, giving the body a chance to fight the cancer.
2. **Trastuzumab**: Trastuzumab is another superhero medicine that targets HER2-positive breast cancer. Like Pertuzumab, it works by blocking the HER2 protein on the surface of cancer cells. By doing this, Trastuzumab helps stop the cancer cells from growing and spreading, just like putting a stop sign in front of them.
Now, when these two medicines are combined, they form a powerful team against HER2-positive breast cancer. They work together to block the HER2 protein from different angles, making it harder for the cancer cells to grow and spread. This combination approach is often more effective than using just one medicine on its own.
Pertuzumab-trastuzumab is usually given as an infusion into a vein (intravenously) by a healthcare provider in a hospital or clinic. The dose and frequency of the infusions depend on factors like the type and stage of cancer being treated, as well as the patient's overall health.
Like any medicine, Pertuzumab-trastuzumab can cause side effects. Some common side effects include feeling tired, having diarrhea, or feeling sick to your stomach. Some people may also experience changes in their skin, like a rash or dryness. These side effects can vary from person to person, but doctors can help manage them to make treatment as comfortable as possible.
Overall, Pertuzumab-trastuzumab is a powerful combination of medicines that helps fight against HER2-positive breast cancer. By targeting the HER2 protein on cancer cells, these medicines give patients a better chance at beating their cancer and living a longer, healthier life.
Have any queries, book a consultation with our Oncology Clinical Specialist
